Cargando…
Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
BACKGROUND: The pre-erythrocytic malaria vaccine RTS,S/AS02A has shown to confer protection against clinical malaria for at least 21 months in a trial in Mozambican children. Efficacy varied between different endpoints, such as parasitaemia or clinical malaria; however the underlying mechanisms that...
Autores principales: | Guinovart, Caterina, Aponte, John J., Sacarlal, Jahit, Aide, Pedro, Leach, Amanda, Bassat, Quique, Macete, Eusébio, Dobaño, Carlota, Lievens, Marc, Loucq, Christian, Ballou, W. Ripley, Cohen, Joe, Alonso, Pedro L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666156/ https://www.ncbi.nlm.nih.gov/pubmed/19365567 http://dx.doi.org/10.1371/journal.pone.0005165 |
Ejemplares similares
-
Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02(D) Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial
por: Aide, Pedro, et al.
Publicado: (2010) -
Impact of the RTS,S Malaria Vaccine Candidate on Naturally Acquired Antibody Responses to Multiple Asexual Blood Stage Antigens
por: Campo, Joseph J., et al.
Publicado: (2011) -
RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection
por: Enosse, Sonia, et al.
Publicado: (2006) -
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial
por: Macete, Eusebio V, et al.
Publicado: (2007) -
Malaria in rural Mozambique. Part I: Children attending the outpatient clinic
por: Guinovart, Caterina, et al.
Publicado: (2008)